These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 15368330

  • 1. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
    Blum W, Mrózek K, Ruppert AS, Carroll AJ, Rao KW, Pettenati MJ, Anastasi J, Larson RA, Bloomfield CD.
    Cancer; 2004 Sep 15; 101(6):1420-7. PubMed ID: 15368330
    [Abstract] [Full Text] [Related]

  • 2. Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461.
    Byrd JC, Lawrence D, Arthur DC, Pettenati MJ, Tantravahi R, Qumsiyeh M, Stamberg J, Davey FR, Schiffer CA, Bloomfield CD.
    Clin Cancer Res; 1998 May 15; 4(5):1235-41. PubMed ID: 9607582
    [Abstract] [Full Text] [Related]

  • 3. Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience.
    Lee KW, Choi IS, Roh EY, Kim DY, Yun T, Lee DS, Yoon SS, Park S, Kim BK, Kim NK.
    Ann Hematol; 2004 Apr 15; 83(4):218-24. PubMed ID: 14628154
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V.
    J Med Assoc Thai; 2009 Sep 15; 92(9):1143-9. PubMed ID: 19772172
    [Abstract] [Full Text] [Related]

  • 5. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
    Jourdan E, Dastugue N.
    Cancer; 2005 Mar 15; 103(6):1316; author reply 1316-7. PubMed ID: 15700268
    [No Abstract] [Full Text] [Related]

  • 6. Translocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia.
    Sandoval C, Head DR, Mirro J, Behm FG, Ayers GD, Raimondi SC.
    Leukemia; 1992 Jun 15; 6(6):513-9. PubMed ID: 1602790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
    Udayakumar AM, Pathare AV, Al-Kindi S, Khan H, Rehmen JU, Zia F, Al-Ghazaly A, Nusrut N, Khan MI, Wali YA, Al-Lamki Z, Dennison D, Raeburn JA.
    Cancer Genet Cytogenet; 2007 Sep 15; 177(2):89-94. PubMed ID: 17854660
    [Abstract] [Full Text] [Related]

  • 9. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
    Marcucci G, Mrózek K, Ruppert AS, Archer KJ, Pettenati MJ, Heerema NA, Carroll AJ, Koduru PR, Kolitz JE, Sterling LJ, Edwards CG, Anastasi J, Larson RA, Bloomfield CD.
    J Clin Oncol; 2004 Jun 15; 22(12):2410-8. PubMed ID: 15197203
    [Abstract] [Full Text] [Related]

  • 10. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
    Yang DH, Lee JJ, Mun YC, Shin HJ, Kim YK, Cho SH, Chung IJ, Seong CM, Kim HJ.
    Am J Hematol; 2007 Jan 15; 82(1):1-5. PubMed ID: 16986129
    [Abstract] [Full Text] [Related]

  • 11. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C, Kern W, Schnittger S, Büchner T, Hiddemann W, Haferlach T.
    Haematologica; 2004 Sep 15; 89(9):1082-90. PubMed ID: 15377469
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
    Marcucci G, Mrózek K, Ruppert AS, Maharry K, Kolitz JE, Moore JO, Mayer RJ, Pettenati MJ, Powell BL, Edwards CG, Sterling LJ, Vardiman JW, Schiffer CA, Carroll AJ, Larson RA, Bloomfield CD.
    J Clin Oncol; 2005 Aug 20; 23(24):5705-17. PubMed ID: 16110030
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
    Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T, Pelliniemi TT, Remes K, Ruutu T, Savolainen ER, Siitonen T, Silvennoinen R, Volin L, Elonen E, Finnish Leukaemia Group.
    Eur J Haematol; 2007 Jun 20; 78(6):477-86. PubMed ID: 17391337
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Krauter J, Wagner K, Schäfer I, Marschalek R, Meyer C, Heil G, Schaich M, Ehninger G, Niederwieser D, Krahl R, Büchner T, Sauerland C, Schlegelberger B, Döhner K, Döhner H, Schlenk RF, Ganser A.
    J Clin Oncol; 2009 Jun 20; 27(18):3000-6. PubMed ID: 19380453
    [Abstract] [Full Text] [Related]

  • 15. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
    Farag SS, Archer KJ, Mrózek K, Vardiman JW, Carroll AJ, Pettenati MJ, Moore JO, Kolitz JE, Mayer RJ, Stone RM, Larson RA, Bloomfield CD.
    Int J Oncol; 2002 Nov 20; 21(5):1041-51. PubMed ID: 12370753
    [Abstract] [Full Text] [Related]

  • 16. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S.
    Haematologica; 2005 Dec 20; 90(12):1617-25. PubMed ID: 16330434
    [Abstract] [Full Text] [Related]

  • 17. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome.
    Chang H, Brandwein J, Yi QL, Chun K, Patterson B, Brien B.
    Leuk Res; 2004 Oct 20; 28(10):1007-11. PubMed ID: 15289011
    [Abstract] [Full Text] [Related]

  • 18. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C, Lacerda JF, Lourenço F, Carmo JA, Lacerda JM.
    Acta Med Port; 2005 Oct 20; 18(5):329-37. PubMed ID: 16611537
    [Abstract] [Full Text] [Related]

  • 19. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
    Tallman MS, Kim HT, Paietta E, Bennett JM, Dewald G, Cassileth PA, Wiernik PH, Rowe JM, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2004 Apr 01; 22(7):1276-86. PubMed ID: 14970186
    [Abstract] [Full Text] [Related]

  • 20. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
    Byrd JC, Ruppert AS, Mrózek K, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Stamberg J, Koduru PR, Moore JO, Mayer RJ, Davey FR, Larson RA, Bloomfield CD.
    J Clin Oncol; 2004 Mar 15; 22(6):1087-94. PubMed ID: 15020610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.